scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M

scPharmaceuticals reports 2021 executive compensation

By ExecPay News

Published: April 28, 2022

scPharmaceuticals reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, two executives at scPharmaceuticals received on average a compensation package of $1.3M, a 9% increase compared to previous year.
Average pay of disclosed executives at scPharmaceuticals
John H. Tucker, Chief Executive Officer, received $1.9M in total, which increased by 7% compared to 2020. 54% of Tucker's compensation, or $1M, was in option awards. Tucker also received $129K in bonus, $165K in non-equity incentive plan, $550K in salary, as well as $13K in other compensation.
Rachael Nokes, Senior Vice President of Finance, received a compensation package of $720K, which increased by 12% compared to previous year. 47% of the compensation package, or $341K, was in salary.

Related executives

John Tucker

scPharmaceuticals

Chief Executive Officer

Rachael Nokes

scPharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on April 28, 2022.